Company intelligence / Profile preview
Mediclone Biotech
Chennai, Tamil Nadu, Indiamediclonebiotech.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Mediclone has developed and commercialized a range of diagnostic kits based on monoclonal antibodies. The company is actively developing therapeutic biomolecules targeting infectious diseases and snake toxins, with ongoing R&D efforts but no published late-stage clinical results as of now.
- Therapeutic areas
- OtherHematologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)Immunoserological kitsTherapeutic biologicals (including anti-rabies and anti-snake venom serum)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
University of Madras (Postgraduate Diploma in Immunotechnology)Alagappa University (M.Sc. Biotechnology specialization in Immunotechnology)
Beyond the preview
Go deeper on Mediclone Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mediclone Biotech.